Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Nimodipine (Primary) ; Nimodipine (Primary)
- Indications Aneurysm; Subarachnoid haemorrhage
- Focus Adverse reactions
- Sponsors Edge Therapeutics
- 13 Mar 2017 According to an Edge Therapeutics media release, first patient has been randomized in this trial. Nerissa U. Ko is investigator of this study. Company expects data from this study in 2017.
- 09 Jan 2017 Status changed from not yet recruiting to recruiting.
- 01 Nov 2016 According to an Edge Therapeutics media release, this trial is expected to initiate patient enrollment in the fourth quarter of 2016.